EE+ POEM Archive
Single IM dose of nirsevimab reduces likelihood of hospitalization due to RSV in average-risk infants during first year of life (HARMONIE)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Single IM Dose of Nirsevimab Reduces Likelihood of Hospitalization Due to RSV in Average-risk Infants During First Year of Life (HARMONIE)." EE+ POEM Archive, John Wiley & Sons, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377077/all/Single_IM_dose_of_nirsevimab_reduces_likelihood_of_hospitalization_due_to_RSV_in_average_risk_infants_during_first_year_of_life__HARMONIE_.
Single IM dose of nirsevimab reduces likelihood of hospitalization due to RSV in average-risk infants during first year of life (HARMONIE). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2024. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377077/all/Single_IM_dose_of_nirsevimab_reduces_likelihood_of_hospitalization_due_to_RSV_in_average_risk_infants_during_first_year_of_life__HARMONIE_. Accessed December 7, 2024.
Single IM dose of nirsevimab reduces likelihood of hospitalization due to RSV in average-risk infants during first year of life (HARMONIE). (2024). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377077/all/Single_IM_dose_of_nirsevimab_reduces_likelihood_of_hospitalization_due_to_RSV_in_average_risk_infants_during_first_year_of_life__HARMONIE_
Single IM Dose of Nirsevimab Reduces Likelihood of Hospitalization Due to RSV in Average-risk Infants During First Year of Life (HARMONIE) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2024. [cited 2024 December 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377077/all/Single_IM_dose_of_nirsevimab_reduces_likelihood_of_hospitalization_due_to_RSV_in_average_risk_infants_during_first_year_of_life__HARMONIE_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Single IM dose of nirsevimab reduces likelihood of hospitalization due to RSV in average-risk infants during first year of life (HARMONIE)
ID - 3377077
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377077/all/Single_IM_dose_of_nirsevimab_reduces_likelihood_of_hospitalization_due_to_RSV_in_average_risk_infants_during_first_year_of_life__HARMONIE_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
